Federated Hermes, Inc. Infinity Pharmaceuticals, Inc. Transaction History

Federated Hermes, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$1.52 - $3.82 $2,290 - $5,756	-1,507 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.66 - $3.47 $1,941 - $2,533	-730 Reduced 32.63%	1,507 $5,000
Q1 2021 May 13, 2021	BUY	$1.98 - $5.36 $2,869 - $7,766	1,449 Added 183.88%	2,237 $7,000
Q4 2020 Feb 12, 2021	BUY	$1.05 - $2.77 $827 - $2,182	788 New	788 $2,000
Q4 2019 Feb 14, 2020	SELL	$0.88 - $1.29 $649 - $952	-738 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$1.03 - $1.75 $1,617 - $2,747	-1,570 Reduced 68.02%	738 $1,000
Q2 2018 Aug 10, 2018	BUY	$1.72 - $2.26 $201 - $264	117 Added 5.34%	2,308 $4,000
Q4 2017 Feb 14, 2018	SELL	$1.22 - $3.73 $2,055 - $6,285	-1,685 Reduced 43.47%	2,191 $0
Q3 2017 Nov 13, 2017	BUY	$0.94 - $1.35 $3,643 - $5,232	3,876	3,876 $5,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.